Angiogenesis in Early Breast Cancer for Prognosis Prediction - Full Text View

Angiogenesis in Early Breast Cancer for Prognosis Prediction

This study is currently recruiting participants.
Verified by University of California, Irvine, July 2008

Sponsored by:	University of California, Irvine
Information provided by:	University of California, Irvine
ClinicalTrials.gov Identifier:	NCT00599105

Purpose

This study will investigate the association of angiogenesis in breast cancer measured by magnetic resonance imaging and biomarkers with long-term prognosis of patients.

Condition	Intervention
Breast Lesions	Procedure: magnetic resonance imaging

Genetics Home Reference related topics:

breast cancer

MedlinePlus related topics:

Breast Cancer Cancer MRI Scans

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Open Label, Single Group Assignment

Official Title:	Angiogenesis in Early Breast Cancer for Prognosis Prediction

Further study details as provided by University of California, Irvine:

Primary Outcome Measures:

To investigate whether breast cancer with a higher angiogenesis activity is associated with a unfavorable outcome. [ Time Frame: 5 years from completion of enrollment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

To investigate whether angiogenesis of breast cancer is associated wit lymph node status [ Time Frame: at completion of enrollment ] [ Designated as safety issue: No ]

Estimated Enrollment:	700
Study Start Date:	November 2000
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Intervention Details:

MRI contrast agent, 0.1 mmol/kg

Eligibility

Ages Eligible for Study:	18 Years to 90 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Patient with a breast mass highly suspicious for malignancy from clinical, mammographic or sonographic examination.
The study has been explained to the patient when she is scheduled for surgery.
Healthy normal volunteers for imaging protocol optimization.

Exclusion Criteria:

Pregnancy
Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material,
Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities,
Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion,
Patients with implanted prosthetic heart valves,
Patients with pacemakers, neuro-stimulation devices,
A breast mass with features of benign tumor
The patients unwilling to participate in the study or fail to sign the consent form

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00599105

Contacts


Contact: Min-Ying Su, PhD	949-824-6001	msu@uci.edu

Locations


United States, California
	Center for Functional Onco-Imaging, University of California	Recruiting
	Irvine, California, United States, 92697
	Contact: Diane Huebner 949-824-6001 dkhuebne@uci.edu
	Principal Investigator: Min-Ying Su, PhD

Sponsors and Collaborators

University of California, Irvine

More Information

Responsible Party:	University of California, Irvine ( Min-Ying Su )
Study ID Numbers:	UCI-HS-2000-1141, NIH-CA90437, CBCRP-9WB-0020
First Received:	January 10, 2008
Last Updated:	July 14, 2008
ClinicalTrials.gov Identifier:	NCT00599105
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Skin Diseases

Breast Neoplasms

Breast Diseases

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Site

ClinicalTrials.gov processed this record on November 30, 2008